Journal Article

ζ-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy

Matthew T. Wheeler, Sara Zarnegar and Elizabeth M. McNally

in Human Molecular Genetics

Volume 11, issue 18, pages 2147-2154
Published in print September 2002 | ISSN: 0964-6906
Published online September 2002 | e-ISSN: 1460-2083 | DOI: http://dx.doi.org/10.1093/hmg/11.18.2147
ζ-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy

Show Summary Details

Preview

The dystrophin glycoprotein complex (DGC) is found at the plasma membrane of muscle cells, where it provides a link between the cytoskeleton and the extracellular matrix. A subcomplex within the DGC, the sarcoglycan complex, associates with dystrophin and mediates muscle membrane stability. Mutations in sarcoglycan genes lead to muscular dystrophy and cardiomyopathy in both humans and mice. In invertebrates, there are three sarcoglycan genes, while in mammals there are additional sarcoglycan genes that probably arose from gene duplication events. We identified a novel mammalian sarcoglycan, ζ-sarcoglycan, that is highly related to γ-sarcoglycan and δ-sarcoglycan. We generated a ζ-sarcoglycan-specific antibody and found that ζ-sarcoglycan associated with other members of the sarcoglycan complex at the plasma membrane. Additionally, ζ-sarcoglycan was reduced at the membrane in muscular dystrophy, consistent with a role in mediating membrane stability. ζ-Sarcoglycan was also found as a component of the vascular smooth muscle sarcoglycan complex. Together, these data demonstrate that ζ-sarcoglycan is an integral component of the sarcoglycan complex and, as such, is important in the pathogenesis of muscular dystrophy.

Journal Article.  4703 words.  Illustrated.

Subjects: Genetics and Genomics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.